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Abstract 
Previous studies have suggested that endotoxin tolerance induces macrophage desensitization to endotoxin through altered guanine 
nucleotide regulatory (G) protein function. In the present study the binding characteristics of the nonhydrolyzable GTP analogue 
GTPT[35S] to macrophage membranes from endotoxin tolerant and control rats were determined. Membranes were prepared from 
peritoneal macrophages harvested from rats 72 h after two sequential daily doses of vehicle or Salmonella enteritidis endotoxin (100 
/xg/kg on day 1 and 500/xg/kg on day 2). GTP3,[35S] bound to a single class of sites that were saturable and displaceable in control and 
endotoxin tolerant macrophage membranes. The maximum specific binding of GTI~[35S] was significantly (P < 0.01) decreased in 
membranes from tolerant rats compared to control (Bm~ x = 39 ___ 7 pmol/mg protein in control vs. 11 _+ 2 pmol/mg protein in endotoxin 
tolerant; n = 5). There were no significant differences in the K d values. To determine whether the reduced GTP3,S binding was due to 
decreases in G proteins, macrophage membrane G protein content was determined by western blotting with specific antisera to Gil,2 t~, 
Gi3ot, Gsa, and the /3 subunit of G. Scanning densitometric analysis demonstrated differential decreases in tolerant macrophage 
membrane G proteins. Gi3 t~ was reduced the most to 48 + 8% of controls (n = 3), and this reduction was significant compared to those 
of other G proteins. Gil,2 ot and G/3 were reduced to 73 + 5% (n = 3) and 65 + 4% (n = 3) of control values, respectively. Gsa(L) and 
G s a(H) were reduced to 61 z 5% (n = 3) and 68 + 3% (n = 3) of control, respectively. These results demonstrate that endotoxin tolerant 
macrophages xhibit decreased membrane GTP binding capacity and differential reductions in the content of specific G proteins. The 
cellular mechanisms leading to such alterations in G proteins and their functional significance in the acquisition of endotoxin tolerance 
merit further investigation. 
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I.  Introduction 
Activation of macrophages by bacterial endotoxin re- 
suits in the release of multiple mediators thought o play a 
major role in the pathogenesis of endotoxic shock. These 
mediators include a variety of cytokines, reactive oxygen 
metabolites, and arachidonic acid metabolites [1,2]. Sub- 
Abbreviations: AA, arachidonic acid; G, guanine nucleotide regula- 
tory proteins; PT, pertussis toxin 
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lethal administration of endotoxin to humans and labora- 
tory animals diminishes macrophage release of certain 
inflammatory mediators, including arachidonic acid (AA) 
metabolites [3,4] and produces resistance to lethal shock 
upon secondary challenge with endotoxin [5-8]. This ac- 
quired resistance to endotoxin is referred to as endotoxin 
tolerance. The molecular mechanisms mediating the refrac- 
tory response of tolerant macrophages to endotoxin stimu- 
lation are not known. Changes in macrophage mediator 
production in endotoxin tolerance do not appear to be a 
consequence of changes in endotoxin receptors but may be 
due to altered intracellular signal transduction events [9-  
11]. 
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The guanine nucleotide regulatory (G) proteins are a 
family of heterotrimeric proteins that couple membrane 
receptors of the serpentine class to certain second messen- 
ger generating enzymes and ion channels [ 12-14]. Pertus- 
sis toxin (PT) catalyzes the ADP ribosylation of ce sub- 
units of the G i family of G proteins resulting in its 
functional uncoupling from membrane receptors [15,16]. 
The involvement of G proteins in endotoxin activation of 
macrophages i  suggested from observations that PT in- 
hibits endotoxin induced PGE 2 formation in rat mesangial 
cells [17], TXB 2 and 6-keto-PGF~ production in rat 
peritoneal macrophages [3], induction of interleukin-lfl 
mRNA in U937 cells [18] and nitric oxide production in 
murine peritoneal macrophages [19]. 
Previous studies have demonstrated that endotoxin tol- 
erant macrophages xhibit reduced AA metabolism when 
stimulated by nonspecific G protein activators such as NaF 
and GTPyS [3,20]. Additionally, we have demonstrated 
decreased macrophage membrane GTPase activity from 
endotoxin tolerant rats [20]. The time of onset of sup- 
pressed membrane GTPase activity after a tolerizing dose 
of endotoxin correlates with the inability of subsequent 
endotoxin exposure to stimulate in vitro TXB 2 production 
in macrophages [20]. These observations suggest an associ- 
ation between decreased G protein function and the devel- 
opment of endotoxin tolerance. To determine if the re- 
duced membrane GTPase activity in endotoxin tolerance is
a consequence of altered substrate binding affinity or 
altered number of binding sites, we examined the binding 
characteristics of GTP to membranes from endotoxin toler- 
ant and control macrophages using the nonhydrolyzable 
GTP analogue GTPy[35S]. Since Gi proteins may be in- 
volved in endotoxin signal transduction, we determined 
whether the reduced macrophage membrane GTPase activ- 
ity in endotoxin tolerance could be due to reduced content 
of Gi proteins. Immunoblot analysis of macrophage mem- 
branes by specific antibodies to Gil,2O~ and Gi3ce were 
performed. Furthermore, to determine whether the content 
of other G proteins could be altered, immunoblot analysis 
of G Sce, and the /3 subunit of G were conducted. 
2. Materials and methods 
2.2. Cell culture 
Macrophages were harvested by peritoneal lavage from 
ether-anesthetized rats with RPMI 1640 medium (GIBCO, 
Grand Island, NY) with L-glutamine containing penicillin 
(50 U/ml), streptomycin (50/zg/ml), and sodium heparin 
(10 U/ml). The cells were allowed to adhere for 2 h on 60 
mm plates at 37°C in 5% CO 2. 
2.3. Preparation of membranes for GTPTS binding 
After adhering for 2 h, the cells were washed 3 times 
with 5% dextrose and lysed by the addition of ice-cold 
lysing buffer (25 mM Tris-HC1, 1 mM EDTA, pH 7.4). 
Macrophages were scraped and homogenized in lysing 
buffer. The suspension was then dounced 13 times and 
centrifuged at 30 000 × g at 4°C for 1 h. The pellet was 
resuspended in lysis buffer, dounced and centrifuged again 
at 30 000 X g for 60 min. The pellet was resuspended in
membrane buffer (20 mM Tris-HC1, 1 mM EDTA, pH 
7.4). 
2.4. GTPy[35S] binding 
Equilibrium binding experiments were conducted in 
incubations containing 20/zl of membrane suspension (2.5 
/xg protein, 20 mM Tris-HC1, 1 mM EDTA, pH 7.4), 30 
/zl of buffer containing 20 mM Tris-HC1 (pH 7.4), 1 mM 
EDTA, 1 mM dithiothreitol (DTT), 20 mM MgC12, 100 
mM NaC1, 0.1% Lubrol (Sigma, St. Louis, MO), 0.15 nM 
GTPT[35S] (1300 Ci/mmol) NEN, Boston, MA) and vary- 
ing concentrations of unlabeled GTPTS (2 nM to 2 /xM). 
Equilibrium was reached by 10 min (data not shown). 
After incubation for 20 min at 30°C, the samples were 
placed on ice, l ml of 20 mM Tris-HCl, 2 mM MgCl 2, pH 
7.4, and 1 mM GTP was added to each sample, followed 
by filtration through a 0.45 /x HAWP filter (Millipore, 
Bedford, MA) which was then washed 3 times with 20 
mM Tris-HC1, 2 mM MgC12, pH 7.4. Nonspecific binding 
was determined in presence of 100-fold excess unlabeled 
GTP and was less than 5% of total. Equilibrium binding 
data were analyzed according to the method of Scatchard 
[21] using the computer program Ligand [22]. 
2.1. Tolerance induction 2.5. Preparation of membranes for Western blotting 
All rats used in these studies were viral antibody-free 
Long Evans male rats (200-250 g) obtained from Charles 
River (Durham, NC). Rats were maintained in double 
filters and reverse flow isolators under controlled tempera- 
ture and illumination and given food and water ad libitum. 
Tolerance was induced by intraperitoneal injection of 
Salmonella enteritidis endotoxin (DIFCO, Detroit, MI) for 
2 consecutive days at doses of 100 and 500 /~g/kg body 
weight, respectively. The experiments were performed 72 
h after the final injection of endotoxin. 
Adherent peritoneal MO were washed 3 times with 5% 
dextrose then lysed and scraped in lysing buffer with 
protease inhibitors (25 mM Tris-HCl, 1 mM EDTA, 0.1 
mM phenylmethylsulfonyl fluoride, l0 /zg/ml leupeptin, 
0.2 /zg/ml pepstatin A, 4°C, pH 7.4). The suspension was 
incubated on ice for 1 h. It was then dounced 13 times and 
centrifuged at 1200 x g, 4°C for 15 min. The pellet was 
resuspended in lysis buffer, dounced and centrifuged again 
at 1200 x g. The supematants from both centrifugations 
were centrifuged for 60 min at 100000Xg at 40(2. The 
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membrane pellet was resuspended in lysis buffer. Protein 
determinations were performed using a protein assay kit 
from BioRad (Richmond, CA). 
2.6. Peptide conjugation and immunization 
For the generation of specific antisera designated ASC 
and AII2, synthetic peptides of the sequence 
RMHLRQYELL, which corresponds to C terminal se- 
quence of G~ c~, and KNNLKDCGLF, which corresponds 
to C terminal sequence of Gil o~ and Gi2 c~, were coupled to 
the carrier protein keyhole limpet hemocyanin (KLH) us- 
ing gluteraldehyde as described by Goldsmith [23]. To 
raise antisera designated BCI,  the peptide 
(C)SWDSFLKIWN, which corresponds to the C terminal 
sequence of /3 subunits, was coupled to KLH by the 
cysteine residue using m-maleimido-benzoyl-n-hydroxy- 
succinimide ster as described by Green [24]. Polyclonal 
antibodies were raised in female New Zealand White 
rabbits according to the procedure described by Green [24]. 
The ASC polyclonal antiserum specifically recognized both 
the large and small forms of Ga S and no other G-protein 
subunits or isoforms in bovine brain. The AII2 antiserum 
recognized the a subunits of Gil and Gi2 purified from 
bovine brain, but not the /3 or 3' subunits, or the 
subunits of GoA, GoB, or G s a. The BCI antiserum recog- 
nizes only the /3 subunit of purified G-proteins and only 
the 27 kDa C-terminal fragment of the /3 subunit gener- 
ated after trypsin treatment. Recombinant Gi3 o~ and rabbit 
antisera to Gi3 a were prepared as previously described 
[251. 
with a 1:4000 diluted horseradish peroxidase linked don- 
key anti-rabbit-IgG antibody (Amersham) for 1 h. The 
membrane was vigorously washed (5 washes, 15 min each) 
with TBS-T (0.15% Tween-20) then incubated with the 
ECL detection reagents (Amersham, Arlington Heights, 
IL). The G protein bands were detected on film by the 
chemiluminescent reaction of luminol [28]. G proteins 
co-migrated with partially purified G proteins from the 
brain [29] and recombinant Gi3 o~. 
2.9. Densitometric scanning analysis 
Western blots were scanned, and the integrated optical 
densities for the G protein bands were calculated using the 
software NIH Image. Initially, several experiments (n = 
5-9) comparing equal amounts of control and tolerant 
membrane proteins demonstrated reductions in tolerant 
macrophage membrane G proteins including GqA 1 or. To 
determine the percent reduction in G protein levels in 
tolerance, standard curves using three different amounts of 
control or tolerant membrane proteins were generated. In 
one experiment, 8, 5.33 and 4 /~g of control macrophage 
membrane proteins were electrophoresed along with 8 ~g 
of tolerant macrophage membrane proteins. The integrated 
optical densities of the control G protein bands linearly 
correlated with the amount of protein loaded. The relative 
amount of tolerant G protein was extrapolated from the 
linear curve generated using the three control bands. Toler- 
ant G protein levels were expressed as percent of control. 
Two similar experiment were performed using 8 /.tg of 
control proteins with 8, 12 and 16 /zg of tolerant proteins. 
2.7. Gel electrophoresis 2.10. Statistical analysis 
One dimensional SDS-polyacrylamide g l electrophore- 
sis was performed according to the method of Laemmli 
[26]. Membrane samples were electrophoresed through 1.5 
mm thick gels with 2.5 cm of a 4.5% acrylamide/bis 
stacking gel and 16 cm of 12% acrylamide resolving gel. 
Coomassie blue staining of membrane proteins was rou- 
tinely performed to ascertain equal protein loading (data 
not shown). 
2.8. Western blot analysis 
Statistical significance for the binding data was deter- 
mined by the Student's t-test. Statistical comparison of 
control and tolerant G protein bands was performed using 
a paired Student's t test with the Bonferroni correction 
applied to allow multiple comparisons. Statistical compari- 
son among the percent levels of tolerant G proteins was 
performed using an analysis of variance followed by 
Tukey's Honestly Significant Difference test. P<0.05  
was considered significant. Data are expressed as means + 
S.E. 
Proteins were electrophoretically transferred from the 
SDS gel to a nitrocellulose membrane [27]. Following 
transfer, the membrane was blocked for 1 h in a solution of 
7.5% dried milk in Tris-buffered saline-Tween-20 (TBS-T) 
(20 mM "Iris, 500 mM NaCi, 0.1% Tween-20, pH 7.5). 
The membrane was subsequently washed with TBS-T 
(once for 15 min then twice for 5 min each) and incubated 
overnight with the rabbit anti-G protein antibody. The 
antibody dilution ranged from 1:1000 to 1:6000 depending 
on the specific antibody used. The following day, the 
membrane was washed as indicated above and incubated 
3. Results 
We assessed the quantity of macrophage membrane 
GTP binding proteins via GTPT[35S] binding. GTPT[35S] 
binding was saturable (Fig. 1 A) and displaceable in control 
and endotoxin tolerant macrophage membranes. Scatchard 
analysis of the equilibrium binding data demonstrated that 
GTPT[35S] binding in nontolerant and endotoxin tolerant 
macrophage membranes was consistent with a single class 
of binding sites (Fig. 1B). The data were best fit by a 
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Fig. 1. (A) Representative equilibrium binding data for GTP~S to control 
(open circles) and tolerant (closed circles) resident peritoneal macrophage 
membranes. Membranes were incubated with various concentrations of
cold and radiolabeled GTI~S. Representative of five experiments. (B) 
Scatchard analysis of equilibrium binding data in A. The Bma x values for 
the control and tolerant groups were 38.5 and 14.5 pmol/mg protein, 
respectively. The K d values were 13 and 20 nM, respectively. Represen- 
tative of five experiments. 
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Fig. 2. Representative Western blots of tolerant (T) and control (C) 
membranes using specific antisera to Gsa, G/3, Gil.2 tx and Gi3ot. 8 /zg 
of control proteins were electrophoresed along with 8, 12, and 16 ~g of 
tolerant proteins. Partially purified G proteins from the brain were used as 
standards (S) except for the Gi3 ot blot where (S) is recombinant Gi3 or. 
Representative of three experiments. 
single site model. Macrophage membranes from endotoxin 
tolerant rats exhibited no significant change in binding 
affinity (K d = 20 + 4 nontolerant vs. 18 + 4 nM endotoxin 
tolerant; n---5), but a significant decrease (P  < 0.01) in 
specific binding capacity (Bm~ x= 39-l-7 nontolerant vs. 
11 _ 2 pmol /mg protein endotoxin tolerant; n = 5). 
Since GTPT[35S] binding was decreased, we determined 
if the content of G proteins was decreased. Immuno- 
blotting for Gil.2 t~, Gi3 or, G s a,  and the fl subunit of G 
were performed and the blots analyzed by densitometric 
scanning. Both control and tolerant membranes demon- 
strated immunoreactivity to all of the Ga  and fl subunits 
(Fig. 2). The membrane content of all G proteins measured 
were reduced in tolerant membranes compared to control 
(Figs. 2 and 3). Densitometric scanning demonstrated that 
the tolerant membrane Gi3 o~ was reduced the most (Fig. 3) 
to 48 4- 8% (n=3,  P<0.05  vs. control, P<0.05  vs. 
other G proteins). Gil,2 ot and Gfl were reduced to 73 _ 5% 
(n = 3) and 65 + 4% (n = 3) of control values, respec- 
tively. G s c~(L) and Gsa(H) which represent the low and 
high molecular weight forms of G~ a were reduced to 
61 + 5% (n = 3) and 68 + 3% (n = 3) of control, respec- 
tively. 
11111 
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G Protein 
*P < 0.05 vs. all other G proteins 
Fig. 3. Tolerant G protein levels expressed as percent of control. The 
blots were analyzed with a scanning densitometer and the relative amount 
of control or tolerant G proteins was extrapolated from a curve as 
described in Section 2. All tolerant G proteins were significantly reduced 
(P  < 0.05) compared to control. Gi3 ot was significantly reduced com- 
pared to the other G proteins. Data are expressed as mean 5: S.E. of three 
experiments. 
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4. Discussion 
This study demonstrates that endotoxin tolerance is 
associated with decreased GTP~/S binding and G protein 
content. Endotoxin activation of specific macrophage me- 
diators, such as AA metabolites, appears to be linked to a 
pertussis toxin sensitive G protein(s) [3,17-20]. Thus, 
alterations in macrophage G protein function could affect 
the decrease in these mediators observed in endotoxin 
tolerance [2,3]. The reduced specific GTP3,S binding and 
the reduced apparent amounts of G i o~, G s a, and the /3 
subunit(s) in membranes from endotoxin tolerant 
macrophages observed in this study are consistent with this 
notion. These findings also extend our previous observa- 
tions of decreases in macrophage membrane GTPase activ- 
ity from endotoxin tolerant rats [20], and reduced AA 
metabolism in these macrophages in response to the non- 
specific G protein activators NaF and GTP'/S [3,20]. 
Down-regulation of G proteins has been suggested as a 
mechanism for heterologous desensitization to certain ago- 
nists after prolonged exposure. Reduced G protein function 
has been implicated in the desensitization f rat aorta after 
prolonged (1 week) norepinephrine infusions. This desensi- 
tization was characterized by reductions in GTP-/S bind- 
ing, contractile responses to NaF, and in the ability of 
alpha adrenergic receptors to activate G i c~ and Gs a pro- 
teins [30]. In rat adipocytes, exposure to either the adeno- 
sine agonist N6-phenyl isopropyl adenosine (PIA) or PGE 1 
leads to down-regulation f each of the three subtypes of 
G i ot and decreased inhibition of adenyl cyclase [31]. Since 
adenosine receptors were not altered by PGE~ exposure, it
was postulated that down-regulation f G i c~ proteins were 
responsible for the resistance of adipocytes to PIA [31]. G i 
proteins could mediate many of the cellular effects of 
endotoxin, including effects on phospholipase A 2, phos- 
pholipase C and adenyl cyciase [32]. In the present studies, 
tolerant macrophage membrane Gi proteins are reduced. 
This is consistent with the observations that in tolerance, 
pertussis toxin sensitive pathways, like AA metabolism are 
suppressed, while other pathways which are not mediated 
by Gi proteins, like nitric oxide and IL-6 production, are 
sustained or even increased [33-35]. It is possible there- 
fore, that in endotoxin tolerance, reduced G protein func- 
tion and content may be responsible for the differential 
regulation of mediator release. 
Heterologous desensitization of post-receptor coupling 
mechanisms as opposed to endotoxin receptor down-regu- 
lation could more readily describe the well established 
phenomenon of cross tolerance that can be induced be- 
tween endotoxin and certain non-endotoxin stimuli. This 
includes cross tolerance to gram-positive bacteria [36], 
TXA 2 mimetics [37], catecholamine-induced shock [38], 
drum trauma [39], oxygen toxicity [40], and reperfusion 
injury in myocardial ischemia [41]. It is unlikely that 
downregulation of endotoxin receptors is responsible for 
this broad desensitization. Indeed, several studies have 
shown that reduced mediator production in tolerance does 
not correlate with LPS receptor changes [9-11]. 
The mechanisms leading to the reduced GTPTS binding 
and G protein content remain to be determined. These 
reductions are not due to non-specific effects of LPS. The 
non-toxic and less potent LPS from Rhodobacter 
spheroides [42,43] caused only slight reductions in G 
protein content (data not shown). In addition, macrophages 
from rats rendered LPS tolerant by injection of TNF, 
which is structurally unrelated to LPS, exhibit reduced 
membrane Gi3 ot content [44]. The reductions in Gi, Gs, Gq 
(data not shown) and G/3 raise the possibility of a com- 
mon mechanism for the reduced G protein content, and 
that other G proteins may also be reduced. The greater 
reduction in Gi3 t~ may be due to an increased susceptibil- 
ity of Gi3 oL or to the presence of a separate mechanism. 
This may involve altered gene transcription, mRNA trans- 
lation or protein degradation. 
The present findings are only correlative. They do not 
show that reduced G protein content and function are the 
mechanisms of LPS tolerance. Other mechanisms for LPS 
tolerance, such as the induction of protein repressors [45] 
or the failure to activate transcription factors [46], have 
been proposed. Nonetheless, in view of the involvement of 
G protein pathways in endotoxin activation of 
macrophages, mechanisms leading to altered cellular G 
protein function and content and the effects of those 
changes on macrophage signal transduction merit further 
investigation. 
Acknowledgements 
The authors are grateful to Janie Nelson for the typing 
of this manuscript. This work was supported in part by 
NIH GM27673 to J.A.C., DK42486 to T.W.G. and 
DK37219 to J.D.H. 
References 
[1] Cook, J.A. and Halushka, P.V. (1989) in Multiple Organ Failure 
(Bihari, D.J. and Cerra, F., eds.), Vol. 1II, pp. 101-124, Society of 
Critical Care Medicine, Fullerton, CA. 
[2] Wise, W.C., Cook, J.A. and Halushka, P.V. (1980) J. Pharmacol. 
Exp. Tiler. 215, 160-164. 
[3] Coffee, K.A., Halushka, P.V., Wise, W.C. and Cook, J.A. (1990) 
Biochim. Biophys. Acta 1035, 201-205. 
[4] Rogers, T.S., Halushka, P.V., Wise, W.C. and Cook, J.A. (1986) 
Prostaglandins 31,639-650. 
[5] Beeson, P.B. (1947) J. Exp. Med. 86, 29-41. 
[6] Chedid, L. and Parant, M. (1971) Microbial Toxins V., Academic 
Press, New York. 
[7] Greisman, S.E., Hornick, R.B., Carozza, F.A. and Woodward, T.E. 
(1964) J. Clin. Invest. 43, 986-999. 
[8] Greisman, S.E. and Hornick, R.B. (1976) in The Role of Immuno- 
logic Factors in Infectious, Allergic, and Autoimmune Processes 
(Beers, R.F. and Bassett, E.G., eds.), pp. 43-50, Raven Press, New 
York. 
168 M. Makhlouf et al. / Biochimica et Biophysica Acta 1312 (1996) 163-168 
[9] Fahmi, H. and Chaby, R. (1993) Cell Immunol. 150, 219-229. 
[10] Labeta, M.O., Durieux, J.J., Spagnoli, G., Fernandez, N., Wijdenes, 
J. and Herrmann, R. (1993) Immunology 80, 415-423. 
[11] McCall, C.E., Grosso, W.L., La, R.K., Guzman, R.N. and Cousart, 
S.L. (1993) J. Clin. Invest. 91,853-861. 
[12] Gilman, A.G. (1987) Annu. Rev. Biochem. 56, 615-649. 
[13] Hepler, J.R. and Gilman, A.G. (1992) Trends Biochem. Sci. 17, 
383-387. 
[14] Birnbaumer, L., Abramowitz, J. and Brown, A.M. (1990) Biochim. 
Biophys. Acta 1031, 163-224. 
[15] Katada, T. and Ui, M. (1982) Proc. Natl. Acad. Sci. USA 79, 
3129-3133. 
[16] Gilman, A.G. (1984) Cell 36, 577-579. 
[17] Wang, J., Kester, M. and Dunn, M.J. (1988) Biochim. Biophys. Acta 
963, 429-435. 
[18] Daniel-Issakani, S., Spiegel, A.M. and Strulovici, B. (1989) J. Biol. 
Chem. 264, 20240-20247. 
[19] Zhang, X. and Morrison, D.C. (1993)J. Immunol. 150, 1011-1018. 
[20] Coffee, K.A., Halushka, P.V., Ashton, S.H., Tempel, G.E., Wise, 
W.C. and Cook, J.A. (1992) J. Appl. Physiol. 73, 1008-1013. 
[21] Scatchard, G. (1949) Ann. N.Y. Acad. Sci. 51,660-672. 
[22] Munson, P.J. and Rodbard, D. (1980) Anal. Biochem. 107, 220-239. 
[23] Goldsmith, P., Gierschik, P., Milligan, G., Unson, C.G., Vinitsky, 
R., Malech, H.L. and Spiegel, A.M. (1987) J. Biol. Chem. 262, 
14683-14688. 
[24] Green, N., Alexander, H., Olson, A., Alexander, S., Shinnick, T.M., 
Sutcliffe, J.G. and Lerner, R.A. (1982) Cell 28, 477-487. 
[25] Gettys, T.W., Sherriff-Carter, K., Moomaw, J., Taylor, I.L. and 
Raymond, J.R. (1994) Analyt. Biochem. 220, 82-91. 
[26] Laemmli, U.K. (1970) Nature 227, 680-685. 
[27] Towbin, H., Staehelin, T. and Gordon, J. (1979) Proc. Natl. Acad. 
Sci. USA 76, 4350-4354. 
[28] Durrant, I. (1990) Nature 346, 297-298. 
[29] Kohnken, R.E. and Hildebrandt, J.D. (1989) J. Biol. Chem. 264, 
20688-20696. 
[30] Johnson, M.D., Wang, H.Y., Ciechanowski, D. and Friedman, E. 
(1991) J. Pharmacol. Exp. Ther. 259, 255-259. 
[31] Green, A., Milligan, G. and Dobias, S.B. (1992) J. Biol. Chem. 267, 
3223-3229. 
[32] Hunt, T.W., Carroll, R.C. and Peralta, E.G. (1994) J. Biol. Chem. 
269, 29565-29570. 
[33] Cavaillon, J.M., Pitton, C. and Fitting, C. (1994) J. Endotoxin Res. 
1, 21-29. 
[34] Zingarelli, B., Halushka, P.V., Caputi, A.P. and Cook, J.A. (1995) 
Shock 3, 102-108. 
[35] Fahmi, H., Perrier, S. and Chaby, R. (1994) J. Endotoxin Res. 1, 61. 
[36] Mancusco, G., Blandino, G., Cusumano, V., Alba Merendino, R., 
Rocca, P., Teti, G. and Cook, J.A. (1994) J. Endotoxin Res. 1, 
114-119. 
[37] Coffee, K.A., Halushka, P.V., Wise, W.C., Tempel, G.E. and Cook, 
J.A. (1991) J. Cardiovasc. Pharmacol. 17, 20-26. 
[38] Lillehei, R.C. and MacLean, L.D. (1958) Physiologist I, 48. 
[39] Zweifach, B.W. (1964) Int. Anesthesiol. Clin. Shock 2, 271-286. 
[40] Frank, L. (1985) J. Appl. Physiol. 58, 819-876. 
[41] Brown, J., Grosso, M., Banerjee, A., Mulvin, D., White, C., Repine, 
J. and Harken, A. (1989) FASEB J. 3, A619-625. 
[42] Golenbock, D.T., Hampton, R.Y., Qureshi, N., Takayama, K. and 
Raetz, C.R. (1991) J. Biol. Chem. 266, 19490-19498. 
[43] Zuckerman, S.H. and Qureshi, N. (1992) Infect. Immun. 60, 2581- 
2587. 
[44] Zingarelli, B., Makhlouf, M., Halushka, P.V., Caputi, A.P. and 
Cook, J.A. (1995) J. Endotoxin Res. 2, 247-254. 
[45] La Rue, K.E. and McCall, C.E. (1994)J. Exp. Med. 180, 2269-2275. 
[46] Takasuka, N., Matsuura, K., Yamamoto, S. and Akagawa, K.S. 
(1995) J. Immunol. 154, 4803-4812. 
